Stay updated on DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial
Sign up to get notified when there's something new on the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page.

Latest updates to the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the detailed objectives and criteria for a study on nusinersen for spinal muscular atrophy, while a new EudraCT number and version revision have been added.SummaryDifference14%
- Check15 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check22 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check58 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting certain services and products, as well as a statement about the absence of posted results. Additionally, a new section indicating 'Results Submitted' has been added.SummaryDifference0.7%
- Check72 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.6%
- Check80 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
Stay in the know with updates to DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DEVOTE Study of Nusinersen in Spinal Muscular Atrophy Clinical Trial page.